| Literature DB >> 34072018 |
George Psillas1, Grigorios G Dimas2, Anastasia Sarafidou1, Triantafyllos Didangelos2, Vasilios Perifanis2, Georgia Kaiafa2, Daphne Mirkopoulou2, Thomas Tegos3, Christos Savopoulos2, Jiannis Constantinidis1.
Abstract
The aim of this study is to evaluate the effects of diabetes mellitus, hypertension and hypercholesterolemia on the clinical presentation and outcome of Bell's palsy. The study (comorbidity) group consisted of 50 patients with Bell's palsy associated with diabetes, hypertension, or hypercholesterolemia; the control group included 46 patients with Bell's palsy, but without comorbid diseases. The House-Brackmann grading system (I to VI) was used in order to assess the initial and final facial functions. Both groups of patients were treated with steroids and the antiviral agent acyclovir. The mean severity of initial facial paralysis was more significant in diabetes, hypercholesterolemia, and hypertension, in comparison to the control group. Patients suffering from Bell's palsy and concomitant comorbidities have a poorer prognosis (HB III-VI) compared to patients without comorbidities. Increased glycosylated hemoglobin A1c levels (>6.7%) were significantly correlated with unsatisfactory facial recovery. The pathogenetic mechanisms by which diabetes, hypercholesterolemia, and hypertension affect the vasa nervosum of facial nerve have been described.Entities:
Keywords: facial nerve; facial palsy; prognosis; recovery rate; risk factors
Year: 2021 PMID: 34072018 DOI: 10.3390/jcm10112357
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241